A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether injections of rhuFab V2 into the eye can
prevent vision loss in patients with age-related macular degeneration, and also to evaluate
the safety of this treatment.